Quarterly report pursuant to Section 13 or 15(d)

Derivative Contracts (Tables)

v3.8.0.1
Derivative Contracts (Tables)
9 Months Ended
Sep. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Fair Values and Presentation of Derivative Financial Instruments
The following table summarizes the fair values and the presentation of our derivative financial instruments in the Condensed Consolidated Balance Sheets:
(In thousands)
Balance Sheet Component
 
September 30,
2017
 
December 31,
2016
Derivative financial instruments:
 
 
 
 
 
Common Stock options/warrants
Investments, net
 
$
2,020

 
$
4,017

Embedded conversion option
2033 Senior Notes, net of discount and estimated fair value of embedded derivatives
 
$

 
$
(16,736
)
Forward contracts
Unrealized gains on forward contracts are recorded in Other current assets and prepaid expenses. Unrealized (losses) on forward contracts are recorded in Accrued expenses.
 
$
(264
)
 
$
39

Summary of Derivative Instrument Losses and Gains Recorded
The following table summarizes the losses and gains recorded for the nine months ended September 30, 2017 and 2016:
 
Three months ended September 30,
 
Nine months ended September 30,
(In thousands)
2017
 
2016
 
2017
 
2016
Derivative gain (loss):
 
 
 
 
 
 
 
Common Stock options/warrants
$
(342
)
 
$
(12
)
 
$
(854
)
 
$
(4,728
)
2033 Senior Notes
(6,829
)
 
(5,795
)
 
3,185

 
(1,061
)
Forward contracts
(379
)
 
106

 
(362
)
 
(100
)
Total
$
(7,550
)
 
$
(5,701
)
 
$
1,969

 
$
(5,889
)